Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
31/05/2016 21:08
June 1 (Reuters) - Parnell Pharmaceuticals Holdings Ltd
PARN.O
* Parnell Pharmaceuticals Holdings announces contract
manufacturing agreement with Merial
* Estimates total value of deal between $7 million and $20
million depending on volume of product purchased by Merial over
10-year term
Source text for Eikon: ID:nGNXMSTUNa
Further company coverage: PARN.O
((Bengaluru Newsroom +91 806 749 1136))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln